Loading...
Loading...
Browse all stories on DeepNewz
VisitOutcome of Lacks' family lawsuit against Novartis over HeLa cells by end of 2024?
Lacks' family wins • 25%
Novartis wins • 25%
Settlement reached • 25%
Case dismissed • 25%
Official court records or news reports confirming the court ruling or settlement
Henrietta Lacks' Family Sues Novartis, Viatris in Maryland on Monday Over HeLa Cells
Aug 5, 2024, 08:48 PM
The family of Henrietta Lacks has filed a federal lawsuit in Maryland on Monday against pharmaceutical companies Novartis and Viatris. The lawsuit alleges that these companies profited from the use of Lacks' tissue cells, known as immortal HeLa cells, which were taken from her body in the 1950s without her consent. This marks the third lawsuit by Lacks' family seeking damages from pharmaceutical giants for the unauthorized use of her cells, which have been instrumental in numerous medical research and development projects.
View original story
Settlement • 25%
Dismissed • 25%
Judgment in favor of Neely family • 25%
Judgment in favor of Penny • 25%
Settlement • 25%
Ruling in favor of plaintiffs • 25%
Ruling in favor of defendants • 25%
Dismissal • 25%
Family wins case • 25%
Family loses case • 25%
Case settled out of court • 25%
Case dismissed • 25%
Georgia couple wins • 25%
Georgia couple loses • 25%
Case is settled out of court • 25%
Case is dismissed • 25%
Family wins • 25%
Hospital wins • 25%
Settlement reached • 25%
Case dismissed • 25%
Roche wins • 25%
Stanford and Foresight win • 25%
Settlement reached • 25%
Case dismissed • 25%
Settlement • 25%
Trial verdict • 25%
Dismissed • 25%
No suit filed • 25%
Dismissed • 25%
Settlement • 25%
Trial Verdict • 25%
Ongoing • 25%
Guilty • 25%
Not Guilty • 25%
Case Dismissed • 25%
Other Outcome • 25%
Settlement • 25%
Dismissed • 25%
Trial verdict for plaintiff • 25%
Trial verdict for defendant • 25%
Yes • 50%
No • 50%
Settlement • 25%
Dismissed • 25%
Trial Verdict • 25%
Ongoing • 25%
Yes • 50%
No • 50%
$10 million to $50 million • 25%
Less than $10 million • 25%
More than $100 million • 25%
$50 million to $100 million • 25%